Posted on 12/20/18
Ocular Therapeutix Added to Nasdaq Biotechnology Index
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/20/18
iCAD Announces $7.0 Million Private Placement
NASHUA, N.H., Dec. 20, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative cancer detection and therapy solutions, today announced . . .
Posted on 12/20/18
Generic Electric: Healthcare IPO May Not Avert A Junk Rating
SummaryGE is looking to sell a stake in Healthcare to help pare debt.GE's debt/EBITDA is 7.0x, which would be considered below investment grade.GE bulls believe a . . .
Posted on 12/20/18
Forget bluebird bio, Amgen Is a Better Biotech Stock
In recent years, bluebird bio (NASDAQ:BLUE) has excited the medical community with terrific results for experimental therapies. Deep-pocketed biotechs and everyday investors have funneled billions into . . .
Posted on 12/20/18
Cumulus Closes $4.5 Million Seed Funding Round
Cumulus Digital Systems, a Massachusetts start-up building an Internet of Tools-powered platform to make industrial facilities safer, cleaner, and more productive
Posted on 12/20/18
ZOLL Recognized by the American Heart Association for Workplace Health Achievement
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced that the company scored Gold Level . . .
Posted on 12/20/18
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity . . .
Posted on 12/20/18
Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture
BOSTON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP) and TriArm Therapeutics, Ltd, today announced they will launch Eden BioCell, Ltd. to lead clinical . . .
Posted on 12/20/18
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million
NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 12/19/18
Provident Healthcare Partners Wins Big at the 10th Annual M&A ATLAS AWARDS
Provident Healthcare Partners was the recipient of three awards at the 10th Annual Americas M&A ATLAS AWARDS: Healthcare Services Investment Bank of the Year; Healthcare Services . . .
Posted on 12/19/18
Beacon Health Options Awards Three-year Grant to Shatterproof
Beacon Health Options announced today that the company made a three-year grant to Shatterproof, a national nonprofit organization dedicated to reducing the devastation substance use disorder . . .
Posted on 12/19/18
Dicerna Announces Closing of Global Licensing and Research Collaboration with Eli Lilly and Company
AMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the closing of the global licensing and research . . .
Posted on 12/19/18
Auron and Elucidata Announce Scientific Collaboration
BOSTON & WELLESLEY, Mass.--(BUSINESS WIRE)--Auron Therapeutics and Elucidata Corporation today announced a scientific collaboration using Elucidata’s AI-based target discovery platform to identify and validate targets for . . .
Posted on 12/19/18
Gilead Sciences and Scholar Rock Announce Strategic Collaboration
FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) and Scholar Rock Holding Corporation (NASDAQ: SRRK) announced today that the companies have entered into . . .
Posted on 12/19/18
ZappRx Inks Agreement with Genentech
BOSTON--(BUSINESS WIRE)--ZappRx announced today that it has entered into an agreement with Genentech. The agreement will start by seeking to improve patient access to specialty drugs . . .
Posted on 12/19/18
X-Chem Enters Strategic Collaboration with Bristol-Myers Squibb
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc., a privately held biotechnology company focused on applying its industry-leading DNA-encoded library drug discovery engine to the generation of novel small molecule . . .
Posted on 12/18/18
Entrada Therapeutics Raises $59 Million Series A
Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics
Posted on 12/18/18
Epizyme Earns $8 Million Milestone Payment from GlaxoSmithKline
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced it has earned an $8 million milestone payment from GlaxoSmithKline (GSK). . . .
Posted on 12/18/18
Company Profile for Cohealo
--(BUSINESS WIRE)--Cohealo finds savings for health systems by increasing the utilization of their medical equipment through proactive data analytics and equipment sharing. With deeper insights into . . .
Posted on 12/18/18
CVS Health: The Forgotten Dividend Growth Stock
SummaryNegativity from the dividend growth and share repurchase program halt due to the Aetna acquisition and irrational Amazon fears provides a good entry point for the . . .
Posted on 12/18/18
Keryx's Long-Awaited Merger With Akebia Complete
SummaryShareholders vote through the final approval required to merge Keryx Biopharmaceuticals with Akebia Therapeutics.The two companies will work together to fight kidney disease with a stronger . . .
Posted on 12/18/18
Biohaven Closes $144M Public Offering Of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting migraine and neurological diseases, including rare . . .
Posted on 12/18/18
Rubius Therapeutics Added to Nasdaq Biotechnology Index
CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, today . . .
Posted on 12/18/18
EyePoint Pharmaceuticals Added to NASDAQ Biotechnology Index
WATERTOWN, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 12/17/18
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases . . .

